MCL1 and acute myeloid leukemia: Our recent work demonstrated that JTE-013 induced the loss of the important pro-survival protein Mcl-1 in acute myeloid leukaemia (AML) cells, recapitulating the results seen with SK1 inhibition, and suggested an oncogenic role for S1P2 downstream of SK1 in this malignancy13.